Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hippocampal Predictors of Cognitive Impairment (HippoPCI) in Breast Cancer Patients

NCT01949376 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01949376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hippocampal Predictors of Cognitive Impairment (HippoPCI) in Breast Cancer Patients
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
December 31, 2019
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cognitive impairment